11/15
01:19 pm
blue
bluebird bio, Inc. (NASDAQ: BLUE) had its "sector perform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $4.00 price target on the stock.
Low
Report
bluebird bio, Inc. (NASDAQ: BLUE) had its "sector perform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $4.00 price target on the stock.
11/15
01:19 pm
blue
bluebird bio, Inc. (NASDAQ: BLUE) had its "sector perform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $4.00 price target on the stock.
Low
Report
bluebird bio, Inc. (NASDAQ: BLUE) had its "sector perform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $4.00 price target on the stock.
11/15
12:43 pm
blue
Rating for BLUE
Low
Report
Rating for BLUE
11/15
12:43 pm
blue
Rating for BLUE
Low
Report
Rating for BLUE
11/15
09:37 am
blue
Rating for BLUE
Medium
Report
Rating for BLUE
11/15
09:37 am
blue
Rating for BLUE
Medium
Report
Rating for BLUE
11/15
08:17 am
blue
bluebird bio, Inc. (NASDAQ: BLUE) was downgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "underweight" rating.
High
Report
bluebird bio, Inc. (NASDAQ: BLUE) was downgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "underweight" rating.
9/25
12:35 pm
blue
Rating for BLUE
Low
Report
Rating for BLUE
9/25
12:35 pm
blue
Rating for BLUE
Low
Report
Rating for BLUE
9/16
09:13 am
blue
bluebird bio, Inc. (NASDAQ: BLUE) had its "neutral" rating re-affirmed by analysts at Cantor Fitzgerald.
High
Report
bluebird bio, Inc. (NASDAQ: BLUE) had its "neutral" rating re-affirmed by analysts at Cantor Fitzgerald.
9/16
08:25 am
blue
Rating for BLUE
Medium
Report
Rating for BLUE